BerGenBio Announces Safety Data from Dose Escalation Phase 1b in First Line NSCLC Patients ...Middle East

News by : (PR Newswire) -
Ph1b data support safety, predictable PK and adequate plasma exposure BERGEN, Norway, Oct. 7, 2024 /PRNewswire/ -- BerGenBio ASA (OSE: BGBIO), a clinical-stage biopharmaceutical company developing novel, selective AXL kinase inhibitors for severe unmet medical needs, announced today...

Hence then, the article about bergenbio announces safety data from dose escalation phase 1b in first line nsclc patients was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( BerGenBio Announces Safety Data from Dose Escalation Phase 1b in First Line NSCLC Patients )

Last updated :

Also on site :

Most Viewed News
جديد الاخبار